A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies

To determine the therapeutic efficacy (13-week and 26-week CNS progression-free survival [PFS], response rate, and overall survival) and safety of intraventricular (IVent) topotecan in patients with neoplastic meningitis (NM), we conducted a phase II, open-label, nonrandomized, single-arm trial of I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Groves, Morris D., Glantz, Michael J., Chamberlain, Marc C., Baumgartner, Karen E., Conrad, Charles A., Hsu, Sigmund, Wefel, Jeffrey S., Gilbert, Mark R., Ictech, Sandra, Hunter, Kathy U., Forman, Arthur D., Puduvalli, Vinay K., Colman, Howard, Hess, Kenneth R., Yung, W.K. Alfred
Formato: Artigo
Idioma:Inglês
Publicado em: Duke University Press 2008
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2613823/
https://ncbi.nlm.nih.gov/pubmed/18316473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2007-059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados